Melissa Cudmore
MRC Career Development Fellow
- Centre for Cardiovascular Science
Contact details
- Tel: 0131 24 26292
- Email: melissa.cudmore@ed.ac.uk
Address
- Street
-
Queens Medical Research Institute
47 Little France Crescent
Edinburgh BioQuarter - City
- Edinburgh
- Post code
- EH16 4TJ
Research summary
Aberrant angiogenesis occurs in numerous pathologies, as a direct cause of disease, as well as contributing to condition severity and clinical outcome. Therapies aimed at promoting angiogenesis to tackle ischaemic disease and reducing angiogenesis in cancers, would have tremendous clinical impact. Vascular endothelial growth factor (VEGF), its tyrosine kinase receptors, VEGFR-1 and VEGFR-2, in homodimer form, are essential for developmental vasculogenesis and angiogenesis, physiological and pathological adult angiogenesis and endothelial homeostasis, but targeting this system for therapeutic angiogenesis has had limited success. Anti-VEGF antibodies and specific receptor inhibitors have proved to be disappointing therapeutically. However, the VEGF system is fundamental for blood vessel genesis, as such is unlikely to be the wrong target, it is paucity in the knowledge of the fine regulation of the VEGF system and feedback mechanisms necessary to inform, when, where and how to deliver the appropriate therapy to target this system effectively. Receptor heterodimerisation is a mechanism used to precisely regulate cell signal and function. Heterodimerisation of VEGF receptors has been widely shown to occur in any cell that co-expresses both receptors, and functional independence of the VEGF heterodimers from VEGF receptor homodimers has been demonstrated, however, much further work is necessary to determine the exact role of VEGF receptor heterodimerisation during vascular development. To investigate the function of the heterodimer between VEGFR-1 and VEGFR-2 (VEGFR1-2), we have generated a novel VEGFR1-2-specific ligand. Using this ligand we have shown that the heterodimer receptor mediates responses previously thought to be via VEGFR-1 homodimers and that VEGFR1-2 can negatively regulate VEGFR-2-mediated functions. Thus, it appears that VEGFR-1 subunits regulate VEGF activity predominantly by forming heterodimer receptors with VEGFR-2 subunits. This is a paradigm shift in the current thinking on the mechanism of action of VEGFR-1 and VEGFR-2 and our work is helping to elucidate the detailed molecular mechansims of VEGF function in physiology and patology
Research activities
-
Placental Morphology Is Associated with Maternal Depressive Symptoms during Pregnancy and Toddler Psychiatric Problems
In:
Scientific Reports
DOI: https://doi.org/10.1038/s41598-017-19133-9
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation
In:
Thrombosis and Haemostasis, vol. 113, pp. 329-337
DOI: https://doi.org/10.1160/TH14-01-0002
Research output: Contribution to Journal › Article (Published) -
Response to Letter Regarding Article, "Dysregulation of Hydrogen Sulfide (H2S) Producing Enzyme Cystathionine gamma-lyase (CSE) Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia"
(2 pages)
In:
Circulation, vol. 129, pp. E517-E518
DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.010273
Research output: Contribution to Journal › Letter (Published) -
Dysregulation of Hydrogen Sulfide Producing Enzyme Cystathionine γ-lyase Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia
(9 pages)
In:
Circulation, vol. 127, pp. 2514-2522
DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.001631
Research output: Contribution to Journal › Article (Published) -
Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1
(9 pages)
In:
European Heart Journal, vol. 33, pp. 1150-1158
DOI: https://doi.org/10.1093/eurheartj/ehr065
Research output: Contribution to Journal › Article (Published) -
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis
In:
Nature Communications, vol. 3
DOI: https://doi.org/10.1038/ncomms1977
Research output: Contribution to Journal › Article (Published) -
Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta
In:
American Journal of Obstetrics & Gynecology (AJOG), vol. 206, pp. 253.e10-5
DOI: https://doi.org/10.1016/j.ajog.2011.11.010
Research output: Contribution to Journal › Article (Published) -
Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo
(10 pages)
In:
Development, vol. 138, pp. 2111-2120
DOI: https://doi.org/10.1242/dev.063933
Research output: Contribution to Journal › Article (Published) -
Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
In:
Vascular cell, vol. 3, pp. 15
DOI: https://doi.org/10.1186/2045-824X-3-15
Research output: Contribution to Journal › Article (Published) -
Angiopoietin-1 induces migration of monocytes in a tie-2 and integrin-independent manner
(12 pages)
In:
Hypertension, vol. 56, pp. 477-85
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.110.155556
Research output: Contribution to Journal › Article (Published) -
Upregulation of Urotensin II Receptor in Preeclampsia Causes In Vitro Placental Release of Soluble Vascular Endothelial Growth Factor Receptor 1 in Hypoxia
(7 pages)
In:
Hypertension, vol. 56, pp. 172-178
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.110.152074
Research output: Contribution to Journal › Article (Published) -
Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells
(9 pages)
In:
Hypertension, vol. 55, pp. 689-97
DOI: https://doi.org/10.1161/HYPERTENSIONAHA.109.136333
Research output: Contribution to Journal › Article (Published) -
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model
(11 pages)
In:
Journal of Cellular and Molecular Medicine, vol. 14, pp. 1857-67
DOI: https://doi.org/10.1111/j.1582-4934.2009.00820.x
Research output: Contribution to Journal › Article (Published) -
Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide
(4 pages)
In:
Circulation Research, vol. 104, pp. 1333-6
DOI: https://doi.org/10.1161/CIRCRESAHA.109.196154
Research output: Contribution to Journal › Article (Published) -
Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
(6 pages)
In:
Biochemical Society Transactions, vol. 37, pp. 1237-42
DOI: https://doi.org/10.1042/BST0371237
Research output: Contribution to Journal › Article (Published) -
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1
(9 pages)
In:
Circulation, vol. 115, pp. 1789-97
DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.660134
Research output: Contribution to Journal › Article (Published) -
The release of nitric oxide from S-nitrosothiols promotes angiogenesis
In:
PLoS ONE, vol. 1, pp. e25
DOI: https://doi.org/10.1371/journal.pone.0000025
Research output: Contribution to Journal › Article (Published) -
Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis
(8 pages)
In:
Circulation Research, vol. 99, pp. 715-22
DOI: https://doi.org/10.1161/01.RES.0000243989.46006.b9
Research output: Contribution to Journal › Article (Published)